The Archive · A Source

ReLive Biotechnologies Announces NDA Approval of SpheChon by the HSA in Singapore

Business Wire January 2024 www.businesswire.com/news/home/20240123428625/en/ReLive-Biotechnologies-Announces-NDA-Approval-of-SpheChon-10-70-spheroidscm-by-the-HSA-in-Singapore-Marking-a-Milestone-in-ReLives-Global-Endeavors